Publication date: Aug 01, 2025
Millions of survivors from severe COVID-19 infection suffer from residual symptoms including anginal chest pain. The pathophysiological mechanisms, particularly the role of coronary microvascular dysfunction (CMD), however, remain elusive. We compared the incidence and endotypes of CMD in patients with angina without obstructive coronary artery disease (ANOCA) between those who had a history of severe COVID-19 infection (COVID group, defined as COVID patients needing supplemental oxygen therapy with SpO2
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | infection |
| disease | MESH | chest pain |
| disease | IDO | role |
| disease | MESH | coronary artery disease |
| disease | IDO | history |
| drug | DRUGBANK | Oxygen |
| disease | MESH | Long Covid |
| disease | MESH | syndrome |
| disease | IDO | quality |
Original Article
(Visited 2 times, 1 visits today)